Citadel Advisors’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-79,300
Closed -$8.11M 9327
2014
Q4
$8.11M Buy
79,300
+6,600
+9% +$633K 0.01% 1560
2014
Q3
$6.29M Buy
72,700
+14,700
+25% +$1.3M 0.01% 1783
2014
Q2
$5.23M Buy
58,000
+6,400
+12% +$479K 0.01% 1800
2014
Q1
$3.8M Sell
51,600
-1,300
-2% -$90.7K ﹤0.01% 2016
2013
Q4
$3.6M Buy
52,900
+29,100
+122% +$1.89M ﹤0.01% 1962
2013
Q3
$1.45M Sell
23,800
-43,767
-65% -$2.67M ﹤0.01% 2703
2013
Q2
$3.76M Buy
+67,567
New +$3.91M 0.01% 1839

Citadel Advisors's COV Position: Q4 2014 in Review

Citadel Advisors sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q4 2014, closing a stake of 2,999,470 shares — an estimated $288M sold.

Citadel Advisors first reported a position in COV in Q2 2013 and held it in 6 quarters. The position peaked at $259M in Q3 2014. 758 funds tracked by Wall St. Rank hold COV as of Q4 2014.

  • Citadel Advisors reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q4 2014 after selling out during the quarter.
  • Citadel Advisors sold 2,999,470 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q4 2014, an estimated $288M.
  • Citadel Advisors first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 6 quarters.
  • Citadel Advisors's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $259M in Q3 2014.
  • 758 funds tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q4 2014.

Based on Citadel Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.